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NZB/NZW F1 (B/W) 1 mine are an experimental model for systemic lupus erythemato- 
sus. They spontaneously develop an autoimmune disease characterized by the formation 
of antibodies to nucleic acids and the development of a fatal immune complex glomeru- 
lonephritis.  There  is an  accelerated  expression  of the disorder in  female animals  (1). 
Genetic  (2), immunologic  (3), and  viral  (4)  factors  are  involved  in  pathogenesis.  A 
disorder of immunologic regulation related to abnormalities in T-cell differentiation and 
function may represent a fundamental derangement in these animals (5). 
The accelerated disease in female B/W mice is associated with an earlier appearance 
of IgG antibodies to DNA and polyadenylic acid (Poly A) (6), an earlier onset and greater 
severity of immune complex nephritis,  and a markedly decreased incidence of survival 
beyond 12 mo (7). Males develop these abnormalities later in life. Prepubertal castration 
of male B/W mice caused an essentially female pattern of disease with 100% mortality at 
11  mo  (8). By contrast,  prepubertal  castration  of female  B/W  mice  had  no  effect  on 
mortality, although it markedly reduced the development of IgG antibodies to Poly A. In 
a preliminary experiment, the administration of androgen to castrated females resulted 
in prolonged survival (8). 
These results suggest that sex hormones modulate the expression of autoimmunity in 
B/W mice, with androgens exerting a protective influence. Androgens delay the switch 
from IgM to IgG antibodies to nucleic acids (8), a differentiation event which is generally 
thymic-dependent  (9), In  B/W  mice,  the  development  of IgG antibodies  to  Poly A  is 
abrogated  by  neonatal  thymectomy (10). These  findings  suggest  that  sex  hormones 
modulate autoimmunity by acting on thymic-dependent regulatory mechanisms. 
In the present report,  prepubertal castration of B/W mice was accompanied 
by the sustained administration of sex hormones. The results demonstrate that 
androgens  and  estrogens  have  opposing  effects  on  disease  expression  and 
survival.  The  possible  therapeutic  use  of  male  hormone  is  suggested.  In 
addition, experiments combining castration with neonatal thymectomy suggest 
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buffered saline; Poly A, polyadenylic acid. 
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that sex  hormones require the thymus in order to express  their immunologic 
effects. 
Materials and Methods 
Mice.  B/W mice were derived from our colony at the University of California Vivarium, San 
Francisco, Calif., and they were maintained at the Fort Miley Veterans Administration Hospital. 
Four separate experimental protocols were followed: (a) prepubertal castration combined with 
hormone implantation at 2 wk of age, {b) retreatment with a second androgen implant at 9 mo of 
age,  (c)  androgen  treatment  of  intact  males  at  8  mo  of  age,  and  (d)  combined  neonatal 
thymectomy and prepubertal castration of males. 
In  the  first  protocol,  there  were  11  sham-operated  males,  32  receiving androgen,  and  21 
receiving  estrogen.  There  were  13  sham-operated  females,  14  receiving  androgen,  and  17 
receiving estrogen. In the retreatment protocol,  10  of the original 32  castrated and  androgen- 
treated  males were used.  Five mice received a  second implant containing androgen,  and five 
received an  empty implant.  As for the females, 6  of the original  14  that  were castrated and 
androgen-treated at 2 wk received a  second implant containing androgen at 9 mo.  These were 
compared with five surviving females from the original sham group. 
In the third protocol, 9 intact males served as shams and 14 received an androgen implant for 
the first time.  All animals were 8 mo of age.  In the fourth experiment, seven male mice were 
subjected to combined thymectomy and castration procedures, and 10 were sham-operated. 
Operative Techniques 
Animals were subjected to castration, or they were sham-operated at 2 wk of age. They were 
anesthetized by intraperitoneal injection of Nembutal. 
OOPHORECTOMY.  A midline incision was made over the abdomen. Ovaries were identified and 
removed using electrocautery. The incision was closed using 6-0 silk suture material. 
ORCHIECTOMY.  Testes  were  delivered  through  a  scrotal  incision.  The  vas  deferens  and 
spermatic vessels were transected using electrocautery, and testes and epididymis were removed. 
Skin was sutured using 6-0 silk suture material. 
THYMECTOMY.  (Controlled suction technique) Thymectomy was carried out at 2 days of age 
under  a  dissecting microscope at  a  magnification of 1.6  x.  At  this magnification, the entire 
mediastinal  cavity  was  in  the  field  of vision.  The  sternal  incision  was  extended  from  the 
manubrium  down  to  the  sixth rib.  We  gently  mobilized the  thymic  lobes by  disrupting the 
vascular and connective tissue attachments. To achieve adequate control of suction intensity, a 3- 
mm  hole was  made in  a  5-cm  tuberculin  syringe barrel  which was interspersed between the 
curved pipette and the rubber tubing connected to the vacuum  outlet.  Each thymic lobe was 
engaged by the pipette at the lower pole and gently teased off.  The entire removal process was 
visualized under the microscope. The mediastinal cavity was left empty. 
Sham  Operation.  In  age-matched sham-operated controls, ovaries,  testes, or thymic lobes 
were identified, but left intact.  Experimental animals were distinguished from sham-operated 
mice by tail  clipping or ear tagging. To  minimize maternal neglect, the surgical incision and 
maternal nasal orifices were painted with parlodion-gentian violet solution. 
Hormone Replacement.  To achieve a maintained :lormone replacement in castrated animals, 
a 2-cm Silastic tube containing 6-7 mg of either estradiol-17-fl or 5-a-dihydrotestosterone  powder 
was  implanted  subcutaneously  immediately  after  the  castration  procedure.  This  treatment 
resulted  in  prompt establishment of an  adequate  hormone level  reached within  12  h,  which 
persisted for at least 3 mo. Sham-operated mice received empty implants. 
Observation.  Mice were observed weekly. Mortality in experimental and control groups was 
tabulated  in  2  ×  2  contingency tables,  and  evaluated  by  Chi  square  analysis  using  Yates 
modification. 
Determination  of Serum  Testosterone  and Dihydrotestosterone  Levels.  Serum samples from 
sham-operated or castrated and androgen-treated male and female mice were pooled separately. 
Serum testosterone and dihydrotestosterone  were measured using a radioimmunoassay similar to 
that described by Abraham (11). Both androgens were purified before assay by celite chromatog- 
raphy and  [:~H]testosterone was added to 0.5-ml serum samples before extraction with ether to 
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serum albumin by the succinate  ester,  and they showed 66% cross-reactivity  with dihydrotestos- 
terone. 
Histopathology.  At ages ranging from 4 to 11 too,  randomly selected  mice from each group 
were sacrificed.  Their  kidneys  were removed and studied  by light  and  electron  microscopy,  and  by 
immunofluorescence for the presence of immune complex deposits.  These examinations were 
performed  before  breaking  the specimen  code.  Light  microscopic  examination  was performed  on  4- 
~m paraffin  sections  stained  with hematoxylin and eosin. 
Direct Immunofluorescence for Glomerular Immunoglobulin Deposition. Cryostat sections 5-t~m 
thick were cut and picked up on Formolgelatin-coated slides,  air-dried for 30 min,  and washed 
twice for 15 min in phosphate-buffered saline (PBS) at pH 7.2.  The slides were placed in a  moist 
chamber, covered with antiserum,  and incubated for 30 min at room temperature in the dark. 
Fluorescein  isothiocyanate-conjugated rabbit polyvalent  anti-mouse  immunoglobulin  (Behring 
Diagnostics, Sommerville, N. J.; lot 656, fluorescein:protein ratio, 2:8) was used at a titer of 1:20. 
Slides were rinsed quickly in PBS and washed twice for 15 min in PBS with gentle agitation, 
rinsed in distilled water,  and mounted in glycerin-PBS. Coated sections were examined using a 
Wild  fluorescence  microscope  (Wild  Heerbrugg  Instruments,  Inc.,  Farmingdale,  N.  Y).  The 
brightness and extent of glomerular immunoglobulin immunofluorescence was graded on a  scale 
of 0-4 by two observers who were calibrated against each other against sections from standard 
specimens used in our laboratory. 
Electron Microscopy.  Mouse kidneys were cut immediately in cold 1% glutaraldehyde in 0.1 
M cacodylate buffer, pH 7.3.  After 1.5 h fixation at room temperature, they were fixed additionally 
in  1%  osmium  tetroxide  in  0.1  M  cacodylate  buffer  (pH  7.3)  for 45  min.  The  specimens were 
dehydrated with alcohol and propylene oxide,  infiltrated with epon-Araldite plastic, and polym- 
erized at 75°C.  Ultra-thin sections were cut on an LKB  Ultratome III  (LKB Instruments, Inc., 
Rockville,  Md.),  stained with  uranyl  acetate  and lead  citrate.  The sections were  examined by 
RCA-EMU  (3F and 4; RCA Solid State, Somerville, N. J.) electron microscopes. 
Representative  areas  of 2  glomeruli from each kidney were photographed  and  printed at  a 
magnification ranging from 2,500  to  15,000  ×.  The areas occupied by immune complexes were 
graded on a  scale of 0-4 independently by two investigators trained in judging renal lesions as 
seen in electron microscopy. 
Fractionation of Serum.  Blood was collected from mice at monthly intervals, starting at the 
third postoperative month. The animals were bled from the orbital sinus. The blood was allowed 
to  clot  at  room  temperature  for  1  h,  and  left  at  4°C  overnight.  Serum  was  separated  by 
centrifugation at 1,200 g  for 10 min. Serum samples from castrated and sham-operated mice were 
pooled separately.  200  gl of the pooled serum samples was subjected to ultracentrifugation in a 
10-35% linear sucrose density gradient (0.15 M NaC1, pH 8.0). Bovine thyroglobulin (19S), human 
gammaglobulin (7S), and hemoglobin (4S) were used as sedimentation markers. 40 fractions were 
collected and each was analyzed for antibodies to DNA and Poly A. Peak fractions were tested for 
immunoglobulin content. In the 19S region (fraction 10-20) only activity against g-chain could be 
detected by Ouchterlony analysis, whereas in the 7S region (fractions 20-30), activity against T- 
chain, but not t~-chain, was present. To determine the specificity of binding, monospecific rabbit 
anti-mouse g-chain and anti-mouse T-chain antisera were added to peak fractions from 19S and 
7S  regions,  respectively.  Anti-g inhibited DNA binding between  77  and  100%,  whereas anti-~, 
inhibited binding between 66 and 78%.  Addition of goat anti-mouse albumin to these gradient 
fractions had no inhibitory effect. 
Anti-DNA  and  Anti-Poly  A  Assays.  Antibodies  to  DNA  and  Poly  A  were  determined 
separately  using a  cellulose ester filter radioimmunoassay.  The radioactive nucleic acids were 
double-stranded DNA (["*H]DNA from KB cells obtained from Electro-Nucleonics Inc., Fairfield, 
N. J.),  and [3H]Polyriboadenylic acid (from Miles Laboratories Inc., Elkhart, Ind.). The radioac- 
tive antigens (750 cpm/7.74 ng Poly A; 700 cpm/3 ng DNA) were incubated with decomplemented 
50-gl aliquots of each fraction for 30 min at 37°C followed by an overnight incubation at 4°C. The 
antigen-antibody complexes were collected onto cellulose ester filters (Millipore Corp.,  Bedford, 
Mass.).  The filters were placed in counting vials and covered with  10 ml of Liquifluor-toluene 
scintillation  medium.  Radioactivity  was  determined  in  a  Packard  liquid  scintillation counter 
(Packard Instrument Co., Inc., Downers Grove, Ill.). The results are expressed as corrected cpm 
retained on the filter, a  value which is directly related to serum concentration (12). 
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FIG.  1.  Effect  of  prepubertal  castration  and  sex  hormone  treatment  on  cumulative 
mortality in male B/W mice. 
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distribution into 7S and 19S peaks of activity after sucrose gradient fractionation. The radioactiv- 
ity  representing the fractionated  7S  and  19S  peaks  within  a  single gradient  were  added  and 
compared for total binding activity. 
Reproducibility and Analysis  of Data.  To determine the reproducibility of our filter radioim- 
munoassay  and  the  variations seen  in  age-matched  mice,  pooled  serum  samples  from  intact, 
sham-operated and variously treated male and female mice were subjected to sucrose gradient 
ultracentrifugation and assayed for anti-DNA antibodies. The ages ranged between 12 and 36 wk. 
The procedures were performed by the same technician. The radioactive DNA used was from the 
same lot.  Some age-matched pooled samples were assayed on the same day, then repeated 1 mo 
later. The variations from the mean for the total anti-DNA binding in the 19S region ranged from 
1.9  to  14.1%,  whereas  in  the  7S  region  the  range  was  between  0.2  and  7.1%.  In  the  present 
communication, a minimum variation of 13% in the IgM and 8% in the IgG total binding activity 
from age- and sex-matched, sham-operated controls was required before a  result was considered 
significant. These values represent 2 SD from the mean. 
Results 
Effects of Sex Hormones on Mortality of B/W Mice.  Prepubertal castration 
combined with maintained  estrogen administration  caused a greatly enhanced 
mortality of male B/W mice (Fig. 1). 19 of 21 mice were dead by 7 mo of age. By 
contrast,  the  cumulative  mortality  at  1 yr was  18% for sham-operated  males 
and  15% for androgen-treated  males  (P  <  0.05).  Castrated  female mice given 
maintained  estrogen  also died more rapidly  than  sham-operated  females.  By 
contrast,  castrated  females  given  androgen  had  a  significant  decrease  in 
mortality  (Fig. 2).  8 of 14 (57%) such animals were alive at 1 yr, compared to 3 
of  13  (23%)  sham-operated  females  (P  <  0.05).  Serum  dihydrotestosterone 
concentrations  in androgen-treated  male and female mice were similar to the 
levels of testosterone observed in sham-operated males and clearly higher than 
those in sham-operated females (Table I). 
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mortality in female B/W mice. 
TABLE  I 
Serum Testosterone 
Group 
Age in months 
4  5  6 
ng/ml 
Sham male  3.04  1,26  3.52 
Castrated and androgen-treated male  6.50  3,33  3.10 
Sham female  1.15  0.45  0.79 
Castrated and androgen-treated female  3.77  3.47  3,10 
B/W Mice.  Castrated male mice receiving estrogen had greater DNA binding 
activity when compared to sham and androgen-treated male mice. The increase 
in IgM antibodies occurred from 3 mo onward  (Fig.  3A),  whereas the major 
increase  of IgG  antibodies  occurred  at  6  mo  (Fig.  3B),  a  time  of greatly 
accelerating mortality. 
Similar results were found for antibodies to Poly A.  Estrogen-treated mice 
had an increase in IgM from 3 mo of age (Fig. 3 C),  and showed a  premature 
appearance of IgG antibodies to Poly A  at 6  mo of age  (Fig.  3 D).  Normally, 
significant amounts of IgG antibodies to Poly A do not appear in male B/W mice 
until 11 mo of age (6, 10). 
Effects  of Sex  Hormones  on  Antibodies  to  DNA  and  Poly A  in  Castrated 
Female B/W Mice.  Castrated female mice receiving androgen had less IgM 
and IgG binding activity for DNA when compared to sham and estrogen-treated 
females (Figs. 4 A and B).  By contrast, mice receiving estrogen had increased 
DNA binding which was particularly striking at 5 mo of age.  The decreased ~ooo 
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(D) IgG antibodies to Poly A. 
binding at  6  mo  may be  due to the  selective death of mice with the  greatest 
amount of anti-DNA antibodies. 
The  effect  of  sex  hormones  on  the  Poly  A  response  had  the  following 
characteristics. The  augmentation due to estrogen was apparent both for IgM 1574 
4,000  - 
A 
3,ooo 
~T 
o  ~ 
2poo  z 
i,000 
CASTRATION  AND  SEX  HORMONE  TREATMENT  IN  NZB/NZW  F 1  MICE 
4ooo 
/•k 
"='  3,00o  -  /  k\  h 
II ESTROGEN  IT 
g 
-   ,ooo 
SHAM 
~/Ct  i0.....~0  ANDROGEN  ~  1,1300  _  ~9 
/ 
/ 
0 
1  1  i  I  I  0 
3  4  5  6  7 
AGE  IN  MONTHS 
4,000 
Cir" 
4,000 --C 
"'  3,000 
39oo- 
c,_  E 
g  ~  2,ooo I 
29oo  z  z 
u  1,000 
u  1,000/%  ~w  %ESTRC~EN 
o  o 
3  4  5  6  7 
AGE  IN  MONTHS 
-B 
/% 
/  % 
/ 
#  %~SHAM 
I  #  ~--~  ANDROGEN 
/ 
g  i  I  i  J 
3  4  5  6  7 
AGE  IN  MONTHS 
i 
D 
~~ 
SHAM 
/  OGEN 
//  //,I~  ANDROGEN 
3  4  5  6  7 
AGE  IN  MONTHS 
FIG.  4.  Effect of prepubertal castration and sex hormone treatment of female B/W mice 
on (A) IgM antibodies to DNA, (B) IgG antibodies to DNA,  (C) IgM antibodies to Poly A, 
and (DI IgG antibodies to Poly A. 
(Fig. 4 C) and IgG (Fig. 4 D), and the decrease due to androgen was apparent in 
IgG anti-Poly A antibodies. 
Effect  of  Sex  Hormones  on  Renal  Pathology,  Sham-operated  animals 
showed  glomerulonephritis  including  progressive  accumulation  of lymphoid +5 
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cells at the calices,  and subsequently around the branches of the renal artery. 
The glomeruli showed eosinophilic thickening of the capillary loops as early as 
4 mo in sham females,  with progressive glomerular enlargement  and replace- 
ment by eosinophilic material.  These changes were seen earlier and were more 
severe in sham-operated females than in sham-operated males. 
At 5 and 8 mo, the lymphoid cell  infiltration  and glomerular abnormalities 
were  more  severe  in  animals  which  had  been  castrated  and  treated  with 
estrogen,  irrespective  of sex.  Furthermore,  males  and  females  castrated  and 
given  androgen  showed  much milder changes.  This  apparent  exacerbation  of 
lesions  by  estrogen  and  the  converse  protective  effect  of androgen  were  less 
apparent at very early and very late stages. 
Immunofluorescence.  Glomeruli  showed  significant  granular  staining  for 
immunoglobulin at the earliest  age examined  (4 mo).  Sham-operated females 
showed  more extensive  and  intense  immunofluorescence  than  sham-operated 
males.  The  exacerbation  of  the  glomerular  changes  by  estrogen  and  the 
protective effects of androgen were apparent in both sexes, particularly at 5 and 
8  mo  (Figs.  5  and  6).  At  9  and  10  mo,  many  castrated  females  treated  with 
androgen  were  still  alive  and  had  relatively  fewer  glomerular  deposits  of 
immunoglobulin compared to the few remaining sham females. 
Electron Microscopy.  The electron microscopic abnormalities present in the 
kidneys  of B/W  mice  have  been  well  described  (13).  In  our studies,  electron 
microscopic  observation  confirmed the  renal  involvement  suggested  by  the 
mortality and immunopathologic findings discussed above. 1576  CASTRATION  AND  SEX  HORMONE  TREATMENT  IN  NZB/NZW  F1  MICE 
Fia.  6.  Representative  examples  of  immunofluorescent  analysis  of kidneys  from  cas- 
trated, 8-mo-old B/W mice: (A) B/W male, castrated and treated with androgen (1 plus); (B) 
B/W  male,  castrated  and treated with estrogen  (3  plus);  (C)  B/W female,  castrated  and 
treated with androgen (2 plus); and (D) B/W female, castrated and treated with estrogen (4 
plus). Original magnification x 312. 
Sham-operated females at 4 mo already showed electron dense deposits in 
their glomeruli.  Renal deposits were  apparent  at  5  mo  in the castrated and 
estrogen-implanted mice, both female and male. These mice showed deposits 
present in the mesangial area, while castrated and androgen-implanted males 
at 5 mo had no deposits.  At 10 mo, androgen-implanted animals still showed 
some protection from renal involvement (Fig. 7 A) when compared to a  sham- 
operated female (Fig. 7 B). 
Retreatment with Androgen at 9 Mo of Age.  By 8 mo of age, antibodies to 
Poly A were essentially the same in sham-operated animals and in those that 
had received androgen once prepubertally (Table II). Without further androgen, 
IgG antibodies to Poly A showed the expected rise at 10 and 11 mo of age in both A 
B 
Fia.  7.  (A)  This  is  a  mesangial  area  (M)  of a  glomerulus  of  a  10-too-old  androgen- 
implanted  female.  There  are  parts  of three  capillary  loops  with  red  blood  cells  present. 
There is a small amount of electron dense deposit (arrow) in the mesangial area.  (B) This is 
a  mesangial  area  (M)  of a  glomerulus  in  a  10-mo-old  sham-operated  female.  There  is 
considerable amount of electron dense immune complex material  (arrows).  There are also 
several mesangial cell nuclei (N) present.  Magnification 5000  ×. 
1577 1578  CASTRATION  AND  SEX  HORMONE  TREATMENT  IN NZB]NZW  F  I MICE 
TABLE II 
Effect of a Second Exposure to Maintained Androgen Treatment at 9 Mo of  Age 
Antibodies  to  Poly A (ng  Poly A bound/0.2  ml serum) 
Group  8 Mo  9 Mo  10 Mo  11 Mo 
IgM  IgG  IgM  IgG  IgM  IgG  IgM  IgG 
Male 
Sham  96.6  24.6  120.1  20.5  127.8  159.8  76  92.5 
Androgen once  120  27.6  131.2  21.6  130.1  130  95  87.4 
Androgen twice  101.9"  49.1"  92  12.8" 
Female 
Sham  88.9  159.4  99.1  204.3  116.5  497  90.4  375.8 
Androgen once  97.8  182.3  ...... 
Androgen twice  -  -  86.3  103.7"  58,9*  117.9"  48.9*  63.5* 
* A value greater than 2 SD from the mean. 
sexes. This suggested that the suppressive effect of androgen had worn off by 
this  time,  and  led  us  to  attempt  a  second  reimplantation of an  androgen- 
containing capsule. The introduction of this additional male hormone at 9 mo of 
age  aborted  the  development of IgG antibodies to  Poly A in  both  male  and 
female castrated mice (Table II). 
Androgen Treatment of Intact Males at 8  Mo of Age.  We have observed a 
spontaneous fall in serum testosterone concentration occurring in noncastrated 
9-mo-old male B/W mice (from 4.7 ng/ml to 1.0 ng/ml). After 9 too, these males 
develop  an  accelerated  disease  associated  with  high  concentrations  of IgG 
antibodies to DNA  (6,  10). This temporal correlation between the decline in 
androgen concentration and worsening of disease led us to institute androgen 
treatment  in  intact  males at  8  mo  of age  by the  implantation of hormone- 
containing capsules. 
The treated male B/W mice had significantly fewer IgG antibodies to DNA 
and  Poly  A  when  compared  to  the  sham-treated  animals.  Moreover,  the 
expected switch to IgG antibodies to Poly A was not seen in the treated mice 
(Figs.  8 A  and  B).  At  19  mo of age,  10  of 14  (71%) treated mice were  alive, 
compared to 4 of 9 (44%) sham-implanted controls (P <  0.005). 
Combined  Neonatal  Thymectomy  and  Perinatal  Castration  of Male  B/W 
Mice.  We have previously reported that neonatal thymectomy of male B/W 
mice results in an accelerated disease associated with premature development 
of IgG antibodies to DNA and enhanced mortality (10). By contrast, neonatal 
thymectomy prevents the development of IgG antibodies to Poly A, suggesting 
that this IgM to IgG switch is thymic-dependent (Fig. 9). 
Perinatal castration of male B/W mice also decreases survival and leads to 
early development of IgG antibodies to DNA (8). In these respects, castration 
resembles  neonatal thymectomy. However,  whereas the  development of IgG 
antibodies to Poly A is virtually abolished by thymectomy (10), it is promoted 
by castration of males (ref. 8,  Fig. 9).  These contrasting effects on the Poly A 
response offered an opportunity to study whether or not this effect of castration 
required the thymus. b- 
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Fro.  8.  Effect  of  androgen  treatment  of  intact,  8-mo-old  male  B/W  mice  on  (A)  IgG 
antibodies to DNA and  (B) IgG antibodies to Poly A. 
Male  B/W mice subjected to combined neonatal thymectomy  and perinatal 
castration developed the expected accelerated disease but failed to develop IgG 
antibodies to Poly A despite the castration  (Fig.  9).  Therefore, the premature 
appearance  of IgG  antibodies  to  Poly  A  that  usually  follows castration  was 
prevented if thymectomy was also performed.  Thus, the dominant influence on 
the IgG Poly A response was attributable to the thymus rather than the gonads. 1580  CASTRATION  AND  SEX  HORMONE  TREATMENT  IN  NZB/NZW  F 1  MICE 
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Fla.  9.  Effect of prepubertal castration, neonatal thymectomy (Tx)  and  combined neo- 
natal thymectomy and prepubertal castration on IgG antibodies to  Poly A  in  male B/W 
mice. 
Discussion 
This study demonstrates that both androgens  and estrogens can modify the 
expression of autoimmunity in B/W mice, with male hormone suppressing and 
female hormone accelerating disease. The sex hormones influence survival, the 
formation  of antibodies  to  DNA  and  Poly  A,  and  the  severity  of immune 
complex nephritis.  These results extend earlier reports that prepubertal castra- 
tion  alone  caused  a  more  severe  disease  in  male  B/W  mice,  suggesting  a 
suppressive  effect  of  androgen  (8,  14).  The  combination  of castration  plus 
maintained hormone administration  used in the current study showed an effect 
of female hormone as well. 
The  immunofluorescent  and  electron  microscopic findings  suggest that  the 
effect of these  hormones  on  antibodies  to  nucleic  acids  and  on  survival  are 
mirrored in the renal histopathology.  Gamma globulin deposition and electron 
dense deposits are reduced in androgen-treated mice, and increased in estrogen- 
treated animals.  The mechanisms accountable for these findings might involve 
antibody formation,  complement activation,  infammatory cell recruitment,  or 
any combination of these or other factors.  Future experiments may be able to 
define these mechanisms  more precisely.  It is of interest  that certain  comple- 
ment components are dependent on androgen for their expression  (15). 
These effects of sex hormones probably explain the greater incidence of lupus 
and other autoimmune  disorders in females (16),  and the tendency to autoim- 
munity  seen  in  Klinefelter's  syndrome  (17).  It  is  interesting  that  the 
female:male ratio in lupus is greatest between menarche  and menopause,  and 
declines  before  puberty  and  with  old  age  (16).  An  abnormality  in  estrogen 
metabolism  perhaps  resulting  in  an  increased  estrogen  activity  has  recently 
been demonstrated in Klinefelter's syndrome (18). Moreover, it has been shown 
that  the testes in these patients  may secrete  10 times the  normal  amount  of 
estrogen (19). ROUBINIAN,  TALAL,  GREENSPAN,  GOODMAN,  AND  SIITERI  1581 
These opposing effects of sex hormones are  not unique to B/W mice,  since 
female  mice  of normal  strains  have  greater  humoral  and  cellular  immune 
responses  than  their  male  littermates  (20, 21). Androgens  tend  to  cause 
lymphocyte depletion  (22, 23)  and  decreased  immunoglobulin concentrations 
(24). Orchidectomy causes an increase in immunologic reactivity (25). There is 
some suggestion that the suppressing effects of androgen require the presence 
of the thymus (21). Our studies in mice subjected to combined castration and 
neonatal thymectomy support this hypothesis. A simple notion consistent with 
current concepts of immunologic regulation would be that androgens promote 
the function of suppressor T cells, whereas estrogens favor the development of 
helper T cells. 
The two experiments in which androgen treatment is instituted between 8 
and 9 mo of age (either by reimplantation or treatment of intact males) suggest 
that male hormone may exert a suppressor effect even in older animals. Intact 
males treated in this  manner live significantly longer than  sham-implanted 
controls. These results suggest that androgen treatment may be beneficial in 
mice with already established autoimmune disease. We have also observed that 
female B/W mice treated with androgen starting at 3 or 6 mo of age live longer 
than sham-treated controls." The therapeutic possibilities inherent in androgen 
administration may be worth consideration in human lupus. 
Summary 
NZB/NZW F~ mice of both sexes were castrated at 2 wk of age and implanted 
subcutaneously with silastic tubes containing either 5-a-dihydrotestosterone or 
estradiol-17-fl.  Mice  receiving  androgen  showed  improved  survival,  reduced 
anti-nucleic acid  antibodies,  or  less  evidence of glomerulonephritis as  deter- 
mined  by  light,  immunofluorescent,  and  electron  microscopy.  By  contrast, 
opposite effects were observed in castrated mice receiving estrogen. 
Intact male NZB/NZW F1  mice received androgen implants at 8 mo, an age 
when they develop an accelerated autoimmune disease associated with a decline 
in serum testosterone concentration. Such treated mice had improved survival 
and reduced concentrations of antibodies to DNA and to polyadenylic acid (Poly 
A). 
Prepubertal  castration  of male  NZB/NZW  F1  mice  results  in  an  earlier 
appearance of IgG antibodies to Poly A. This effect of castration was prevented 
if neonatal thymectomy was also performed. 
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